ATRA Atara Biotherapeutics, Inc.
Healthcare$9.80+4.93%ClosedMarket Cap: $88.3M
As of 2026-05-25
Insider Statistics (Q2 2026)
Acquisitions
1
Dispositions
3
Buy/Sell Ratio
0.33
Net Shares
+186,306
Shares Acquired
507,407
Shares Disposed
321,101
Total Bought ($)
$1.00
Total Sold ($)
$3.00
Recent Insider Trades
| Filing Date | Name | Type | Action | Shares | Price | Shares After |
|---|---|---|---|---|---|---|
| Wed May 20 | Nguyen AnhCo | director, officer: President and CEO | Sell | 5,241 | $9.13 | 137,837 |
| Wed May 20 | Grant-Huerta Yanina | officer: Chief Accounting Officer | Sell | 2,414 | $9.13 | 49,636 |
| Mon May 11 | Panacea Innovation Ltd | 10 percent owner | Sell | 313,446 | $10.10 | 1,011,000 |
| Mon May 11 | EcoR1 Capital, LLC | 10 percent owner | Buy | 507,407 | $9.35 | 1,552,000 |
| Mon May 11 | EcoR1 Capital, LLC | 10 percent owner | Sell | 0 | $0.00 | 1,044,593 |
| Thu Mar 19 | Panacea Innovation Ltd | 10 percent owner | Sell | 259,163 | $0.00 | 307,899 |
| Thu Mar 19 | Panacea Innovation Ltd | 10 percent owner | Sell | 5 | $5.23 | 307,894 |
| Wed Mar 11 | Nguyen AnhCo | director, officer: President and CEO | Sell | 81,100 | $0.00 | 143,078 |
| Wed Mar 11 | Grant-Huerta Yanina | officer: Chief Accounting Officer | Sell | 20,300 | $0.00 | 52,050 |
| Wed Mar 04 | Nguyen AnhCo | director, officer: President and CEO | Sell | 198 | $5.08 | 64,776 |
| Wed Mar 04 | Grant-Huerta Yanina | officer: Chief Accounting Officer | Sell | 1,603 | $5.08 | 32,227 |
| Wed Mar 04 | Grant-Huerta Yanina | officer: Chief Accounting Officer | Sell | 377 | $5.08 | 31,850 |
| Wed Mar 04 | Grant-Huerta Yanina | officer: Chief Accounting Officer | Sell | 100 | $5.08 | 31,750 |
| Wed Mar 04 | Grant-Huerta Yanina | officer: Chief Accounting Officer | Sell | 24 | $5.08 | 33,830 |